Tom Gibbs

Member of the Board since June 2017

Tom Gibbs (b. 1963) is Director at Debiopharm Innovation Fund, Switzerland where he is responsible for new investments in smart data companies in the healthcare space. He is currently a Director on the boards of Immunexpress and Diagnoplex and was previously a Director on the Boards of GenePOC and Biocartis.

He has more than 25 years’ experience in the commercialization of life science technologies, split equally between the pharmaceutical industry and scientific tool developers. Senior management experience in both start-ups and established companies in Europe and the USA (including Molecular Devices Corp, Covalys, Med Discovery, Debiopharm), with responsibilities including quality assurance, operations, late-stage product development and marketing, and business development.

Dr. Gibbs holds a Ph.D. in molecular microbiology from the University of Warwick.